Inventor · disambiguated record
David A. Weber
Also filed as: WEBER DAVID · WEBER DAVID A
34 granted patents·28 pending applications·991 citations·filing 2002–2025
98Inventor score
Files withALLERGAN INC32SANTEN PHARMACEUTICAL CO LTD10CSL BEHRING L L C6KEE SCOTT M2KLEINMAN DAVID M2
Top patents by PatentIndex Score
62 records- 0199US8911768B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2014·Granted Dec 16, 2014·88 cites·3 claims
- 0298US7090681B2Methods and apparatus for delivery of ocular implantsALLERGAN INC·Filed 2003·Granted Aug 15, 2006·213 cites·7 claims
- 0397US8034370B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·8 claims
- 0497US8034366B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·9 claims
- 0596US8318070B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Nov 27, 2012·39 cites·5 claims
- 0696US7468065B2Apparatus for delivery of ocular implantsALLERGAN INC·Filed 2004·Granted Dec 23, 2008·116 cites·7 claims
- 0795US8367097B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2010·Granted Feb 5, 2013·31 cites·14 claims
- 0894US10702539B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2018·Granted Jul 7, 2020·3 cites·19 claims
- 0994US8927005B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 6, 2015·20 cites·20 claims
- 1094US8802129B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2013·Granted Aug 12, 2014·7 cites·4 claims
- 1194US7753916B2Methods and apparatus for delivery of ocular implantsWEBER DAVID A·Filed 2006·Granted Jul 13, 2010·47 cites·19 claims
- 1293US9192511B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2013·Granted Nov 24, 2015·10 cites·11 claims
- 1393US8048445B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2008·Granted Nov 1, 2011·14 cites·8 claims
- 1492US10076526B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2015·Granted Sep 18, 2018·6 cites·8 claims
- 1591US8506987B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Aug 13, 2013·12 cites·13 claims
- 1691US8486960B2Formulations and methods for vascular permeability-related diseases or conditionsKLEINMAN DAVID M·Filed 2012·Granted Jul 16, 2013·17 cites·9 claims
- 1790US8663639B2Formulations for treating ocular diseases and conditionsDOR PHILIPPE J M·Filed 2008·Granted Mar 4, 2014·37 cites·11 claims
- 1888US8124736B2Alpha-1-antitrypsin compositionsKEE SCOTT M·Filed 2010·Granted Feb 28, 2012·11 cites·13 claims
- 1988US2024238312A1Ocular implant made by a double extrusion processALLERGAN INC·Filed 2024·Application pending·0 cites
- 2086US6899717B2Methods and apparatus for delivery of ocular implantsALLERGAN INC·Filed 2002·Granted May 31, 2005·194 cites·5 claims
- 2183US9387165B2Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 12, 2016·3 cites·7 claims
- 2283US8722624B2Alpha-1-antitrypsin compositions and methods of useKEE SCOTT M·Filed 2012·Granted May 13, 2014·5 cites·14 claims
- 2382US8637070B2Rapamycin formulations and methods of their useMUDUMBA SREENIVASU·Filed 2006·Granted Jan 28, 2014·4 cites·8 claims
- 2481US2023172948A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2022·Application pending·0 cites
- 2580US9320783B2Methods of treatment using alpha-1-antitrypsin compositionsCSL BEHRING L L C·Filed 2015·Granted Apr 26, 2016·2 cites·28 claims
- 2679US9233071B2Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2014·Granted Jan 12, 2016·0 cites·8 claims
- 2779US8222271B2Formulations and methods for vascular permeability-related diseases or conditionsKLEINMAN DAVID M·Filed 2007·Granted Jul 17, 2012·3 cites·9 claims
- 2879US7777006B2Method for purification of alpha-1-antitrypsinCSL BEHRING L L C·Filed 2002·Granted Aug 17, 2010·9 cites·55 claims
- 2977US10335467B2Methods of treatment using alpha-1-antitrypsin compositionsCSL BEHRING L L C·Filed 2018·Granted Jul 2, 2019·1 cites·30 claims
- 3077US2008241222A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3177US2008172014A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3277US2008241220A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3377US2008241221A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3477US2008233171A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3577US2008233173A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3676US9381153B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 5, 2016·1 cites·2 claims
- 3776US2021113592A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2020·Application pending·0 cites
- 3874US9950046B2Methods of treatment using alpha-1-antitrypsin compositionsCSL BEHRING L L C·Filed 2016·Granted Apr 24, 2018·1 cites·14 claims
- 3972US11224643B2Methods of treatment using alpha-1-antitrypsin compositionsCSL BEHRING L L C·Filed 2019·Granted Jan 18, 2022·0 cites·20 claims
- 4070US2005244469A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2004·Application pending·0 cites
- 4170US2006233859A1Methods for treating retinopathy with extended therapeutic effectALLERGAN INC·Filed 2005·Application pending·0 cites
- 4270US2012329850A1Methods for treating retinopathy with extended therapeutic effectWHITCUP SCOTT M·Filed 2012·Application pending·0 cites
- 4369US2008241219A1Extended therapeutic effect ocular implant treatmentsALLERGAN INC·Filed 2008·Application pending·0 cites
- 4467US8778381B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2013·Granted Jul 15, 2014·0 cites·5 claims
- 4567US7147644B2Apparatus for delivery of ocular implantsALLERGAN INC·Filed 2004·Granted Dec 12, 2006·32 cites·21 claims
- 4665US2018311152A1Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4764US2017266109A1Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4863US2025319031A1Methods of treatment of ocular conditions with a sustained drug delivery implantALLERGAN INC·Filed 2025·Application pending·0 cites
- 4962US9452156B2Formulations and methods for vascular permeability-related diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Sep 27, 2016·0 cites·8 claims
- 5062US2014323405A1Alpha-1-antitrypsin compositionsCSL BEHRING L L C·Filed 2014·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →